![PDF) Pharmacodynamic Models of Differential Bortezomib Signaling Across Several Cell Lines of Multiple Myeloma PDF) Pharmacodynamic Models of Differential Bortezomib Signaling Across Several Cell Lines of Multiple Myeloma](https://i1.rgstatic.net/publication/329420626_Pharmacodynamic_Models_of_Differential_Bortezomib_Signaling_Across_Several_Cell_Lines_of_Multiple_Myeloma/links/5c07dd2ba6fdcc494fdb46e3/largepreview.png)
PDF) Pharmacodynamic Models of Differential Bortezomib Signaling Across Several Cell Lines of Multiple Myeloma
![Faculty Profile - New York State Center of Excellence in Bioinformatics & Life Sciences - University at Buffalo Faculty Profile - New York State Center of Excellence in Bioinformatics & Life Sciences - University at Buffalo](http://pharmacy.buffalo.edu/content/dam/pharmacy/Photos/faculty_staff_profiles/qingma.jpg)
Faculty Profile - New York State Center of Excellence in Bioinformatics & Life Sciences - University at Buffalo
![Buffalo 66: Amazon.de: Vincent Gallo, Christina Ricci, Anjelica Huston, Vincent Gallo, Vincent Gallo, Christina Ricci: DVD & Blu-ray Buffalo 66: Amazon.de: Vincent Gallo, Christina Ricci, Anjelica Huston, Vincent Gallo, Vincent Gallo, Christina Ricci: DVD & Blu-ray](https://images-eu.ssl-images-amazon.com/images/I/51seAE5MjDL._AC_UL600_SR426,600_.jpg)
Buffalo 66: Amazon.de: Vincent Gallo, Christina Ricci, Anjelica Huston, Vincent Gallo, Vincent Gallo, Christina Ricci: DVD & Blu-ray
![PDF) General pharmacokinetic model for drugs exhibiting target-mediated drug disposition | William Jusko - Academia.edu PDF) General pharmacokinetic model for drugs exhibiting target-mediated drug disposition | William Jusko - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43419156/mini_magick20190216-31840-12k4m7s.png?1550313644)
PDF) General pharmacokinetic model for drugs exhibiting target-mediated drug disposition | William Jusko - Academia.edu
![PDF) Bridging Clinical Outcomes of Canakinumab Treatment in Patients With Rheumatoid Arthritis With a Population Model of IL-1β Kinetics PDF) Bridging Clinical Outcomes of Canakinumab Treatment in Patients With Rheumatoid Arthritis With a Population Model of IL-1β Kinetics](https://i1.rgstatic.net/publication/247771942_Bridging_Clinical_Outcomes_of_Canakinumab_Treatment_in_Patients_With_Rheumatoid_Arthritis_With_a_Population_Model_of_IL-1b_Kinetics/links/02e21c310cf2bd9b23c7c1db/largepreview.png)
PDF) Bridging Clinical Outcomes of Canakinumab Treatment in Patients With Rheumatoid Arthritis With a Population Model of IL-1β Kinetics
![Peter BLOOMINGDALE | PhD Student | Doctor of Philosophy | University at Buffalo, The State University of New York, NY | SUNY Buffalo | Department of Pharmaceutical Sciences Peter BLOOMINGDALE | PhD Student | Doctor of Philosophy | University at Buffalo, The State University of New York, NY | SUNY Buffalo | Department of Pharmaceutical Sciences](https://i1.rgstatic.net/ii/profile.image/565327601254400-1511796011935_Q512/Peter_Bloomingdale.jpg)
Peter BLOOMINGDALE | PhD Student | Doctor of Philosophy | University at Buffalo, The State University of New York, NY | SUNY Buffalo | Department of Pharmaceutical Sciences
![Faculty Profile - New York State Center of Excellence in Bioinformatics & Life Sciences - University at Buffalo Faculty Profile - New York State Center of Excellence in Bioinformatics & Life Sciences - University at Buffalo](http://pharmacy.buffalo.edu/content/dam/pharmacy/Photos/faculty_staff_profiles/rms.jpg)